miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis.
about
miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@en
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@nl
type
label
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@en
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@nl
prefLabel
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@en
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@nl
P2093
P2860
P356
P1476
miR-30a as Potential Therapeut ...... Idiopathic Pulmonary Fibrosis.
@en
P2093
Changjun Lv
Guohong Cao
Huizhu Liu
Jinjin Zhang
Songzi Zhang
Xiaodong Song
P2860
P356
10.3390/IJMS18030633
P407
P577
2017-03-15T00:00:00Z